GlassScriptPhysician profile
Carter Keith Andersen
NPI 1427344142
$3,687.72
in general payments reported to CMS, 2019-2025
20 companies · $308 in 2025
The $308 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $239 · 2020: $479 · 2021: $878 · 2022: $649 · 2023: $501 · 2024: $634 · 2025: $308.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,443.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,443.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $701.34 | 2020-2025 | Total30, Precision7 |
| Johnson & Johnson Vision Care, INC. | $643.64 | 2019-2025 | Acuvue |
| Glaukos Corporation | $361.72 | 2021-2023 | Kxl System (Refurbished), Kxl1b-Ce-Marked Kxlsystem |
| Tarsus Pharmaceuticals, INC. | $268.28 | 2024-2025 | Xdemvy |
| Optos, INC. | $257.69 | 2020-2021 | |
| Bausch & Lomb Americas INC. | $253.59 | 2022-2024 | Infuse |
| Amgen INC. | $146.56 | 2024 | Tepezza |
| Sight Sciences, INC. | $136.16 | 2021-2022 | |
| Sun Pharmaceutical Industries INC. | $135.66 | 2020-2021 | |
| Coopervision INC. | $128.53 | 2019-2025 | Myday Contact Lens |
| Abbvie INC. | $107.76 | 2024 | |
| Apellis Pharmaceuticals, INC. | $103.27 | 2023 | Syfovre |
| Rxsight INC | $100.23 | 2020 | |
| Novartis Pharmaceuticals Corporation | $87.43 | 2019-2022 | |
| Biotissue Holdings INC. | $74.43 | 2020-2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ivantis, INC | $67.75 | 2021 | |
| Lkc Technologies, INC. | $41.73 | 2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $30.36 | 2019 | |
| Harrow Eye, LLC | $29.84 | 2025 | Vevye |
| Allergan, INC. | $11.75 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carter Andersen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.